lower back pain result from degenerative disc changes. Loin pain, Low back strain, Lumbago NOS
Conditions
Interventions
Intervention 1: Control group: In this group, non-steroidal anti-inflammatory drug will be prescribed within two months. Celecoxib 100 mg capsules, will be used every 12 hours
(Orally). Interven
Treatment - Drugs
Control group: In this group, non-steroidal anti-inflammatory drug will be prescribed within two months. Celecoxib 100 mg capsules, will be used every 12 hours
(Orally)
Intervention group: In this group, non-steroidal anti-inflammatory drug and also Piascledine will be prescribed within two months.
Piascledine 300 mg capsules, once a day and Celecoxib 100 mg capsule
Sponsors
Ahvaz Jundishapur University Of Medical Sciences, Ahvaz, Iran
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age of 20- 60 years; having modic changes type one and two Identified by MRI; Patients’ pains have not been lasting for more than 6 months; the patient should not have surgical indication. Exclusion Criterion: Having diabetes
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of pain. Timepoint: Before the intervention and two months after the intervention begins. Method of measurement: By VAS questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Daily function of patients. Timepoint: Before the intervention and two months after the intervention begins. Method of measurement: Based on Roland Morris questionnaire.;Walking rate. Timepoint: Before the intervention and two months after the intervention begins. Method of measurement: Based on Roland Morris questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPardis Vakili
Ahvaz Jundishapur University Of Medical Sciences, Ahvaz, Iran
Outcome results
None listed